BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

ARMI | BioFabUSA will be participating in JPM Week 2027, joining industry leaders, investors, innovators, and strategic partners for conversations focused on the future of advanced biomanufacturing and the commercialization of next-generation biotherapeutics. Throughout the week, members of the ARMI team will be connecting with organizations interested in advancing manufacturing technologies, scaling innovative therapies, and exploring opportunities for collaboration.
We welcome the opportunity to connect with industry colleagues, current and prospective partners, and organizations interested in learning more about ARMI | BioFabUSA. To inquire about meeting with our team during JPM Week, please contact events@armiusa.org.